GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, ...

AI tools are transforming EHR datasets into actionable clinical insights by identifying disease patterns, predicting ...

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...

If mishandled, this move could undermine public trust in the FDA and squander a once-in-a-generation opportunity to lead the ...

AdvaMed, the MedTech Association, released its AI Policy Roadmap (the Roadmap) outlining policy priorities for Congress and the U.S. Food and Drug Administration (FDA).

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

We recently published a list of the 10 Most Popular AI Stocks to Avoid Now. In this article, we are going to take a look at ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

Artificial intelligence is revolutionizing the way we care for animals. Once limited to reactive treatments at vet clinics, ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

Tech companies are focusing on AI products over research, say industry experts, who are sounding the alarm about safety.